Witnessing the stock’s movement on the chart, on Thursday, Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) had a quiet start as it plunged -1.92% to $0.57,
Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) on Tuesday, soared 1.35% from the previous trading day, before settling in for the closing price of $0.59. Within
Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) started the day on Thursday, with a price decrease of -0.55% at $0.63, before settling in for the price
Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) on Monday, plunged -4.86% from the previous trading day, before settling in for the closing price of $0.66. Within
A new trading day began on Tuesday, with Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) stock price down -3.43% from the previous day of trading, before
As on Wednesday, Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) got off with the flyer as it spiked 6.62% to $0.73, before settling in for the
A new trading day began on Friday, with Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) stock price up 3.93% from the previous day of trading, before
On Tuesday, Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) opened higher 13.41% from the last session, before settling in for the closing price of $0.60. Price
Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) flaunted slowness of -23.28% at $0.59, before settling in for the price of $0.77 at the close. Taking a
On Monday, Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) was 3.41% up from the session before settling in for the closing price of $0.80. A 52-week
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
